ORANTINIB
UNII 9RL37ZZ665

Substance Identification & Data

This profile provides standardized clinical and technical data for Orantinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9RL37ZZ665.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 252916-29-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9RL37ZZ665

CAS Registry Number

252916-29-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ORANTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H18N2O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

NHFDRBXTEDBWCZ-ZROIWOOFSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C1884

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

5329099

Unique identification number in the NCBI database of chemical substances.

INN ID

9267

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cc1c(CCC(=O)O)c(C)[nH]c1/C=C\2/c3ccccc3NC2=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Orantinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.